
EVOTEC SE - SPON ADR
EVO · NASDAQ
Updated at 2026-11-16 20:57:40
- Today's High
- $1.60
- Today’s Low
- $1.57
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.61
- Previous Close
- $1.58
- Volume
- 46.51K
- Market Cap
- $561.51M
- P/E Ratio
- --
- EPS
- $-1.10
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- ESSENER BOGEN 7, HAMBURG, GERMANY, 22419
- Country
- DE
- Listing Date
- 1999-10-11
- Fiscal Year End
- December
- Shares Outstanding
- 177.95M
- CIK
- 0001412558
- Website
- www.evotec.com
Evotec SE is a prominent global biotechnology company headquartered in Hamburg, Germany, specializing in delivering comprehensive drug discovery and development solutions to the pharmaceutical and biotech industries. The firm is distinguished by its collaborative strategy, forming partnerships with leading pharmaceutical entities and prestigious academic institutions to accelerate the progress of a diverse range of therapeutic programs, including small molecules, biologics, and cell therapies. With a strong and growing pipeline, Evotec is strategically positioned to leverage new opportunities within the biopharmaceutical sector, reaffirming its essential contribution to healthcare innovation and improved patient outcomes.
Financial Metrics
Revenue
2026-09-30
$164.92M
2026-06-30
$145.85M
2026-03-31
$159.22M
2025-12-31
$253.27M
Operating Expenses
2026-09-30
$46.91M
2026-06-30
$50.36M
2026-03-31
$54.75M
2025-12-31
$216.06M
Net Income
2026-09-30
-$26.74M
2026-06-30
-$47.42M
2026-03-31
-$123.94M
2025-12-31
$14.62M
Net Profit Margin
2026-09-30
-16.21%
2026-06-30
-32.51%
2026-03-31
-77.84%
2025-12-31
5.77%
Earnings Per Share
2026-09-30
$-0.07
2026-06-30
$-0.13
2026-03-31
$-0.34
2025-12-31
$0.04
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-09-30
-$18.11M
2026-06-30
-$27.12M
2026-03-31
-$97.35M
2025-12-31
$33.22M
Effective Tax Rate
2026-09-30
-21.43%
2026-06-30
3.05%
2026-03-31
0.19%
2025-12-31
--
| Item | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | $164.92M | $145.85M | $159.22M | $253.27M |
| Operating Expenses | $46.91M | $50.36M | $54.75M | $216.06M |
| Net Income | -$26.74M | -$47.42M | -$123.94M | $14.62M |
| Net Profit Margin | -16.21% | -32.51% | -77.84% | 5.77% |
| Earnings Per Share | $-0.07 | $-0.13 | $-0.34 | $0.04 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$18.11M | -$27.12M | -$97.35M | $33.22M |
| Effective Tax Rate | -21.43% | 3.05% | 0.19% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.